BUY The Indian Hotels Company Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)12 May 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
IHCL reported strong Q2 FY2027 results with a 21% increase in consolidated revenue to INR 2,566 crores and a 23% rise in PAT to INR 349 crores. The company also upgraded its FY2027 revenue growth guid
BSE · Company Update·21 Oct · today
3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·19 Oct · 2d ago
IHCL Fixes June 23 Record Date for ₹3.25 Dividend
NewsGoogle News·18 Oct · 3d ago
Indian Hotels adds 47 signings: what it means for Indian Hotels stock
NewsGoogle News·14 Oct · 1w ago
IHCL reported 47 new hotel signings and 20 openings in H1 FY 2027, reaching a 670-hotel portfolio.
BSE · Company Update·12 Oct · 1w ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·21 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on The Indian Hotels Company
- BUY — Laxmikant Shukla, YES Securities21 Oct 2026 · ~2 weeks · target ₹795 · Active
- BUY — Rakesh Bansal19 Oct 2026 · ~3 months · target ₹840 · Active
- BUY — Kunal Bothra19 Oct 2026 · ~2 weeks · target ₹800 · Active
- BUY — Ajit Mishra, Religare19 Oct 2026 · ~2 weeks · target ₹850 · SL hit
- BUY — Chandan Taparia, Motilal Oswal18 Oct 2026 · ~2 weeks · target ₹815 · SL hit
More from ICICI Securities
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active
- BUY Crompton Greaves Consumer Electricals19 Oct 2026 · ~1 year · target ₹275 · Active

